2.6 Theranostics

Theranostics combines diagnostics and therapeutics, using nanoparticles to detect diseases early and deliver targeted treatments. This approach improves patient outcomes by enabling precise, personalized care and real-time monitoring of therapeutic responses.

Nanoparticles used in theranostics can be inorganic, organic, or hybrid, with properties like small size and high surface area. These particles can be engineered for various imaging techniques and drug delivery methods, offering advantages over traditional approaches.

Definition of theranostics

• Theranostics is a combination of the terms "therapeutics" and "diagnostics" involves developing agents that can simultaneously diagnose a disease and deliver targeted therapy
• Theranostic approaches aim to improve patient outcomes by enabling earlier detection, more precise treatment, and real-time monitoring of therapeutic response
• In the context of nanobiotechnology, theranostics often involves the use of engineered nanoparticles that can perform both diagnostic imaging and targeted drug delivery functions

Advantages of theranostics vs traditional approaches

• Allows for earlier detection and treatment of diseases compared to traditional diagnostic methods that may only detect advanced stages
• Enables targeted delivery of therapeutics specifically to diseased tissues or cells, reducing side effects and improving efficacy compared to systemic drug administration
• Provides real-time monitoring of therapeutic response, allowing for personalized adjustments to treatment plans based on individual patient responses
• Streamlines the drug development process by combining diagnostic and therapeutic functions into a single agent, potentially reducing costs and time to market

Nanoparticles for theranostics

Types of nanoparticles used in theranostics

Top images from around the web for Types of nanoparticles used in theranostics

• 

  Frontiers | Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for ... View original

  Is this image relevant?

• 

  Frontiers | Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical ... View original

  Is this image relevant?

• 

  Frontiers | Nanoconstructs for theranostic application in cancer: Challenges and strategies to ... View original

  Is this image relevant?

• 

  Frontiers | Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for ... View original

  Is this image relevant?

• 

  Frontiers | Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Types of nanoparticles used in theranostics

• 

  Frontiers | Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for ... View original

  Is this image relevant?

• 

  Frontiers | Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical ... View original

  Is this image relevant?

• 

  Frontiers | Nanoconstructs for theranostic application in cancer: Challenges and strategies to ... View original

  Is this image relevant?

• 

  Frontiers | Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for ... View original

  Is this image relevant?

• 

  Frontiers | Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical ... View original

  Is this image relevant?

1 of 3

• Inorganic nanoparticles such as gold nanoparticles, quantum dots, and magnetic nanoparticles possess unique optical, magnetic, or electronic properties that can be harnessed for diagnostic imaging and therapy
• Organic nanoparticles including liposomes, polymeric nanoparticles, and dendrimers can encapsulate or conjugate both imaging agents and therapeutic payloads
• Hybrid nanoparticles that combine inorganic and organic components (core-shell nanoparticles) can integrate the advantages of both material types for theranostic applications

Properties of nanoparticles for theranostic applications

• Small size (typically 1-100 nm) allows for efficient penetration and accumulation in diseased tissues such as tumors via the enhanced permeability and retention (EPR) effect
• High surface area-to-volume ratio enables functionalization with multiple diagnostic and therapeutic moieties on a single nanoparticle
• Tunable surface properties (charge, hydrophobicity) can be engineered to improve stability, biocompatibility, and targeting specificity
• Responsive properties (pH, temperature, magnetic field) can be designed to trigger drug release or activate therapeutic functions in response to specific stimuli

Synthesis methods of theranostic nanoparticles

• Top-down approaches involve breaking down bulk materials into nanoscale structures, such as lithography or laser ablation techniques
• Bottom-up approaches involve building nanoparticles from molecular precursors, such as chemical reduction, sol-gel synthesis, or self-assembly methods
• Surface modification techniques (ligand exchange, polymer coating) are used to functionalize nanoparticles with targeting ligands, imaging agents, and therapeutic payloads post-synthesis

Diagnostic applications of theranostic nanoparticles

Imaging modalities used with theranostic nanoparticles

• Optical imaging techniques such as fluorescence and bioluminescence can be enabled by incorporating fluorescent dyes or quantum dots into theranostic nanoparticles
• Magnetic resonance imaging (MRI) can be enhanced by using magnetic nanoparticles (iron oxide) as contrast agents
• Computed tomography (CT) imaging can be improved by using high atomic number nanoparticles (gold) as contrast agents
• Nuclear imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) can be performed by radiolabeling theranostic nanoparticles

Targeting strategies for diagnostic theranostics

• Passive targeting relies on the EPR effect to accumulate nanoparticles in diseased tissues with leaky vasculature (tumors, inflammation sites)
• Active targeting involves functionalizing nanoparticles with ligands (antibodies, peptides, aptamers) that bind specifically to receptors overexpressed on target cells
• Magnetic targeting uses an external magnetic field to guide magnetic nanoparticles to a specific location in the body

Examples of diagnostic theranostic systems

• Gold nanoshells conjugated with near-infrared fluorescent dyes and tumor-targeting antibodies for combined photoacoustic imaging and photothermal therapy of cancer
• Iron oxide nanoparticles functionalized with cancer-targeting peptides and radiolabeled for PET/MRI dual-modal imaging of tumors
• Quantum dots encapsulated in polymeric nanoparticles and conjugated with disease-specific antibodies for targeted fluorescence imaging and drug delivery in cardiovascular diseases

Therapeutic applications of theranostic nanoparticles

Drug delivery with theranostic nanoparticles

• Nanoparticles can encapsulate small molecule drugs, proteins, or nucleic acids to protect them from degradation and enable controlled release at target sites
• Stimuli-responsive nanoparticles can be designed to release drugs in response to specific triggers (pH, temperature, enzymes) present in the disease microenvironment
• Multifunctional nanoparticles can co-deliver multiple drugs with synergistic effects or combine drug delivery with other therapeutic modalities (gene therapy, phototherapy)

Gene therapy using theranostic nanoparticles

• Nanoparticles can deliver nucleic acids (siRNA, miRNA, plasmid DNA) to target cells for gene silencing or expression
• Cationic lipid or polymer-based nanoparticles can complex with negatively charged nucleic acids to form stable nanostructures that facilitate cellular uptake and endosomal escape
• Theranostic nanoparticles can enable real-time monitoring of gene delivery and expression using reporter genes or imaging agents

Photodynamic therapy and theranostics

• Photodynamic therapy (PDT) involves the use of light-activated photosensitizers to generate reactive oxygen species that induce cell death
• Theranostic nanoparticles can be designed to deliver photosensitizers specifically to target cells and enable imaging-guided activation of PDT
• Examples include upconverting nanoparticles that convert near-infrared light to visible light for activating photosensitizers, and plasmonic nanoparticles that generate localized heat for combined PDT and photothermal therapy

Examples of therapeutic theranostic systems

• Liposomes co-loaded with chemotherapeutic drugs and MRI contrast agents for image-guided drug delivery to solid tumors
• Gold nanorods functionalized with siRNA and near-infrared dyes for combined gene silencing and photothermal therapy of multidrug-resistant cancers
• Polymeric nanoparticles encapsulating photosensitizers and conjugated with tumor-targeting peptides for image-guided photodynamic therapy of brain tumors

Challenges and limitations of theranostics

Toxicity concerns of theranostic nanoparticles

• Nanoparticles can exhibit dose-dependent toxicity due to their small size and high surface reactivity, which may lead to oxidative stress, inflammation, or organ damage
• Long-term fate and clearance of nanoparticles from the body remain a concern, as some nanoparticles may accumulate in organs (liver, spleen, lungs) and cause delayed toxicity
• Interactions between nanoparticles and biological systems (proteins, cells, tissues) can alter their physicochemical properties and lead to unintended effects

Regulatory hurdles for theranostic nanomedicine

• Theranostic nanoparticles combining diagnostic and therapeutic functions may face challenges in regulatory approval pathways designed for single-function products
• Demonstrating the safety and efficacy of theranostic nanoparticles in clinical trials may require novel study designs and endpoints that capture both diagnostic and therapeutic outcomes
• Lack of standardized methods for characterizing and quality control of theranostic nanoparticles can hinder their translation from bench to bedside

Scalability and manufacturing issues

• Synthesis of theranostic nanoparticles often involves complex, multi-step processes that may be difficult to scale up for commercial production
• Batch-to-batch variability in nanoparticle size, composition, and functionality can affect their performance and reproducibility
• Storage stability and shelf-life of theranostic nanoparticles may be limited by the degradation or leakage of active components over time

Future directions of theranostic nanomedicine

Emerging theranostic nanoplatforms

• Exosomes, cell-derived nanovesicles with natural targeting abilities and biocompatibility, are being engineered as theranostic nanocarriers for cancer and other diseases
• DNA nanostructures (origami, tetrahedrons) offer programmable scaffolds for precisely organizing diagnostic and therapeutic components at the nanoscale
• Biomimetic nanoparticles that mimic the properties of natural entities (cells, viruses) are being developed for enhanced stealth, targeting, and delivery capabilities

Combination therapies using theranostics

• Theranostic nanoparticles can be designed to deliver multiple therapeutic modalities (chemotherapy, radiotherapy, immunotherapy) for synergistic effects and overcoming treatment resistance
• Combining theranostic nanoparticles with external stimuli (ultrasound, magnetic fields, light) can enable spatiotemporal control of therapeutic activation and enhance treatment precision
• Theranostic nanoparticles can be integrated with other emerging technologies (microfluidics, 3D printing, artificial intelligence) for developing personalized, closed-loop therapies

Personalized medicine and theranostics

• Theranostic approaches can enable patient stratification based on molecular imaging biomarkers to identify responders vs. non-responders to specific therapies
• Real-time monitoring of therapeutic response using theranostic nanoparticles can inform adaptive treatment planning and dose optimization based on individual patient responses
• Integration of theranostic data with multi-omics profiling (genomics, proteomics, metabolomics) can provide a systems-level understanding of disease mechanisms and guide the development of precision nanomedicines